Literature DB >> 15509636

Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function.

Abeda Mulla1, Carel Leroux, Egle Solito, Julia C Buckingham.   

Abstract

Annexin 1 (ANXA1), a Ca(2+) and phospholipid binding protein, is an important mediator of the antiinflammatory actions of glucocorticoids. However, although inflammatory responses in man are sensitive to alterations in adrenocortical function, the relationship between endogenous cortisol and ANXA1 expression has not been explored. Accordingly, we measured serum cortisol levels and ANXA1 expression in peripheral blood leukocytes from subjects with normal and dysregulated cortisol secretion before and 30 min after a standard corticotrophin (ACTH) test. Our data demonstrate a highly significant correlation between the serum cortisol concentration and the expression of ANXA1 in neutrophils, both before and after ACTH treatment, and thus suggest that ANXA1 may serve as a marker of glucocorticoid sensitivity. They also reveal a correlation between ANXA1 and the serum gonadotrophins, LH and FSH, and an age-related reduction in ANXA1 expression in lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509636     DOI: 10.1210/jc.2004-1230

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Mining relational paths in integrated biomedical data.

Authors:  Bing He; Jie Tang; Ying Ding; Huijun Wang; Yuyin Sun; Jae Hong Shin; Bin Chen; Ganesh Moorthy; Judy Qiu; Pankaj Desai; David J Wild
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

Review 2.  Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.

Authors:  Mauro Perretti; Jesmond Dalli
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

3.  The effect of anaerobic exercise on salivary cortisol, testosterone and immunoglobulin (A) in boys aged 15-16 years.

Authors:  Non Eleri Thomas; Anna Leyshon; Michael G Hughes; Bruce Davies; Michael Graham; Julien S Baker
Journal:  Eur J Appl Physiol       Date:  2009-08-11       Impact factor: 3.078

4.  Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia.

Authors:  Simon McArthur; Enrico Cristante; Mario Paterno; Helen Christian; Federico Roncaroli; Glenda E Gillies; Egle Solito
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

Review 5.  [Adrenal cortex and steroids. Supplementary therapy in the perioperative phase].

Authors:  A S Milde; B W Böttiger; M Morcos
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

6.  Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytes.

Authors:  Suchita Nadkarni; Dianne Cooper; Vincenzo Brancaleone; Stefania Bena; Mauro Perretti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 7.  Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.

Authors:  Mauro Perretti; Fulvio D'Acquisto
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

8.  An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis.

Authors:  Raffaele Simeoli; Giuseppina Mattace Raso; Claudio Pirozzi; Adriano Lama; Anna Santoro; Roberto Russo; Trinidad Montero-Melendez; Roberto Berni Canani; Antonio Calignano; Mauro Perretti; Rosaria Meli
Journal:  Br J Pharmacol       Date:  2016-11-03       Impact factor: 8.739

Review 9.  Annexin-A1: a pivotal regulator of the innate and adaptive immune systems.

Authors:  F D'Acquisto; M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

10.  Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation.

Authors:  Ellen L Hughes; Patricia O Cover; Julia C Buckingham; Felicity N E Gavins
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.